• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

HHS fetal tissue research ban threatens progress toward cure for HIV

Bioengineer by Bioengineer
June 6, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Statement from IDSA President Cynthia Sears, MD, FIDSA and HIVMA Chair W. David Hardy, MD

The Department of Health and Human Services’ announcement Wednesday that it will halt funding for research involving the use of human fetal tissue conducted within the National Institutes of Health, and review funding for research at extramural research universities with potential new restrictions, will significantly imperil our most promising strategies to develop a cure for HIV and other life-threatening diseases, while soundly undermining the administration’s stated commitment to ending the HIV epidemic.

The department’s decision discounts the life-saving value of a research model that is considered a gold standard, and that is critical to developing treatments for devastating diseases. With no validated established alternatives to replace fetal tissue research and the critical possibilities it provides to model human blood and immune system cells, the department’s policy represents a resolute rejection of science. Further, this ban sets back growing hopes for progress that studies of fetal tissue have offered against some of the greatest threats to human life and health that we face today.

With ongoing challenges to preventing and treating HIV, as well as to protecting the lives of persons living with HIV, the administration’s decision poses a profound setback to research towards a cure for HIV, and towards a vaccine to protect against the virus. It will have deeply damaging effects on the potential for improved and healthier lives for people living with HIV and other life-threatening illnesses.

As associations of more than 11,000 infectious diseases specialists, HIV providers and researchers working on the frontlines of the pandemic, the Infectious Diseases Society of America and its HIV Medicine Association urge the administration to reconsider the ban and for Congress to take all steps possible to override this damaging restriction and preserve the promise of biomedical research.

###

Media Contact
Lauren M Martin
[email protected]

Tags: AIDS/HIVInfectious/Emerging DiseasesMedicine/HealthPolicy/EthicsScience/Health and the Law
Share12Tweet7Share2ShareShareShare1

Related Posts

Inhibitor Discovered from Halophilic Litchfieldia Bacterium

October 28, 2025

How Outdoor, Indoor Noise and Sensitivity Affect Health

October 28, 2025

Enhancing Nurses’ Seizure Management Through Flipped Learning

October 28, 2025

Amlodipine Targets Glioma Stem Cells by Degrading EGFR

October 28, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1287 shares
    Share 514 Tweet 321
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    310 shares
    Share 124 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    198 shares
    Share 79 Tweet 50
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    135 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Non-Contrast Transperineal Ultrasound in Pediatric Care

Remote Radiology’s Surprising Impact on Greenhouse Gas Emissions

Inhibitor Discovered from Halophilic Litchfieldia Bacterium

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.